Substance P immunoreactivity in Rett syndrome

被引:45
作者
Deguchi, K
Antalffy, BA
Twohill, LJ
Chakraborty, S
Glaze, DG
Armstrong, DD
机构
[1] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA
[2] Rett Ctr, Houston, TX USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 187, Japan
[5] Kitasato Univ, Sch Med, Dept Pediat, Kanagawa, Japan
关键词
D O I
10.1016/S0887-8994(00)00120-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Severe autonomic dysfunction occurs in Rett syndrome (RS), Substance P, a tachykinin peptide that localizes to several brain regions, including the autonomic nervous system, is reduced in the cerebrospinal fluid of patients with RS, The anatomic localization and intensity of substance P immunoreactivity and glial fibrillary acidic protein-positive astrocytes in the brains of 14 patients with RS were compared with those in the brains of 10 age-matched normal patients. Substance P immunoreactivity expression was significantly decreased in RS tissue compared with control tissue in the following regions: dorsal horns, intermediolateral column of the spinal cord, spinal trigeminal tract, solitary tract and nucleus, parvocellular and pontine reticular nuclei, and locus ceruleus, A less significant decrease of substance P immunoreactivity occurred in the substantia nigra, central gray of the midbrain, frontal cortex, caudate, putamen, globus pallidus, and thalamus, Antiglial fibrillary acidic protein-positive astrocytes were increased in the areas in which substance P immunoreactivity was decreased and in other brain regions. Because many of the brain regions with the greatest decrease in substance P immunoreactivity are involved in the control of the autonomic nervous system, especially the solitary tracts and reticular formation, reduced substance P may contribute to the autonomic dysfunction in RS. (C) 2000 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:259 / 266
页数:8
相关论文
共 28 条
[1]   Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 [J].
Amir, RE ;
Van den Veyver, IB ;
Wan, M ;
Tran, CQ ;
Francke, U ;
Zoghbi, HY .
NATURE GENETICS, 1999, 23 (02) :185-188
[2]  
Armstrong DD, 1998, NEW DEVELOPMENTS IN CHILD NEUROLOGY, P183
[3]  
BRUSNIKOV GA, 1984, PHARMACOL THERAPEUT, V25, P23
[4]   CEREBROSPINAL-FLUID STUDIES IN THE RETT SYNDROME - BIOGENIC-AMINES AND BETA-ENDORPHINS [J].
BUDDEN, SS ;
MYER, EC ;
BUTLER, IJ .
BRAIN & DEVELOPMENT, 1990, 12 (01) :81-84
[5]  
CAMPOSCASTELLO J, 1991, PEDIATRICS, V6, P340
[6]  
CHANG MM, 1970, J BIOL CHEM, V245, P4784
[7]   RETTS SYNDROME - CHARACTERIZATION OF RESPIRATORY PATTERNS AND SLEEP [J].
GLAZE, DG ;
FROST, JD ;
ZOGHBI, HY ;
PERCY, AK .
ANNALS OF NEUROLOGY, 1987, 21 (04) :377-382
[8]   DISTRIBUTION OF SUBSTANCE P-LIKE IMMUNOREACTIVE NEURONS IN THE HUMAN MEDULLA-OBLONGATA - CO-LOCALIZATION WITH MONOAMINE-SYNTHESIZING NEURONS [J].
HALLIDAY, GM ;
LI, YW ;
JOH, TH ;
COTTON, RGH ;
HOWE, PRC ;
GEFFEN, LB ;
BLESSING, WW .
SYNAPSE, 1988, 2 (04) :353-370
[9]   ELEVATED CSF GLUTAMATE IN RETT SYNDROME [J].
HAMBERGER, A ;
GILLBERG, C ;
PALM, A ;
HAGBERG, B .
NEUROPEDIATRICS, 1992, 23 (04) :212-213
[10]   Interactions and coexistence of neuropeptides and serotonin in spinal autonomic systems [J].
Helke, CJ ;
Yang, L .
NEUROPEPTIDES: BASIC AND CLINICAL ADVANCES, 1996, 780 :185-192